IBUPROFEN DISPOSITION IN OBESE INDIVIDUALS

被引：45
作者：
ABERNETHY, DR [1 ]
GREENBLATT, DJ [1 ]
机构：
[1] TUFTS UNIV,NEW ENGLAND MED CTR,DIV CLIN PHARMACOL,BOSTON,MA 02111
来源：
ARTHRITIS AND RHEUMATISM | 1985年 / 28卷 / 10期
关键词：
D O I：
10.1002/art.1780281006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1117 / 1121
页数：5
相关论文
共 30 条
[1]   THE INFLUENCE OF OBESITY ON THE PHARMACOKINETICS OF ORAL ALPRAZOLAM AND TRIAZOLAM [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
DIVOLL, M ;
SMITH, RB ;
SHADER, RI .
CLINICAL PHARMACOKINETICS, 1984, 9 (02) :177-183
[2]  
ABERNETHY DR, 1983, J LAB CLIN MED, V101, P873
[3]  
ABERNETHY DR, 1984, AM J GASTROENTEROL, V79, P91
[4]   OBESITY, SEX, AND ACETAMINOPHEN DISPOSITION [J].
ABERNETHY, DR ;
DIVOLL, M ;
GREENBLATT, DJ ;
AMEER, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (06) :783-790
[5]  
ABERNETHY DR, 1984, J CLIN PHARMACOL, V24, P409
[6]  
ABERNETHY DR, 1981, J PHARMACOL EXP THER, V217, P681
[7]   LIDOCAINE DISPOSITION IN OBESITY [J].
ABERNETHY, DR ;
GREENBLATT, DJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (08) :1183-1186
[8]   PHARMACOKINETICS OF DRUGS IN OBESITY [J].
ABERNETHY, DR ;
GREENBLATT, DJ .
CLINICAL PHARMACOKINETICS, 1982, 7 (02) :108-124
[9]  
ADAMS SS, 1969, ARCH INT PHARMACOD T, V178, P115
[10]  
ALBERT KS, 1984, AM J MED, V77, P47, DOI 10.1016/S0002-9343(84)80018-2
123